SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (508)11/16/2006 10:18:35 AM
From: Thomas  Read Replies (2) of 671
 
Hi Nigel,
Surprising that they only have a 17mm GBP market cap. SR Pharma bought atugen which was a spinoff of RZYM way back when. There were some licensing deals of IP, so now I guess SR and Merck will be partners. Any idea what the indication is that their 027 candidate is aimed at? How does one buy London listed stocks anyway.
Cheer,s
Thomas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News